Stay updated with breaking news from Emisar Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Welcome to Competition Currents, a monthly newsletter for Greenberg Traurig clients and colleagues highlighting significant recent developments in global antitrust and competition law.
Commission pauses major biopharma transaction involving drugs priced in the hundreds of thousands of dollars. As part of the Federal Trade Commission's promised campaign to protect competition in the...
We noted that the Inflation Reduction Act’s IRA focus on pharmaceutical manufacturers ignored a key player in the pharmaceutical supply chain — the Pharmacy Benefit Manager.
In November of 2022, we predicted a fertile post-election congressional landscape for Pharmacy Benefit Manager (PBM) practice reform. Six months into the 118th Congress, we can confirm...
The Federal Trade Commission has altogether issued compulsory orders to the six-largest phamacy benefit managers and three affiliated group purchasing organizations.